Tocilizumab and sarilumab are classified as humanized monoclonal antibodies against the interleukin-6 receptor and are used in rheumatology.
CADTH has conducted a Technology Review on tocilizumab and sarilumab for their potential use in managing COVID-19.
Link to Report
Was this site helpful?
If you couldn’t find what you are looking for, please submit a request.